StemCells, Inc. (NASDAQ:STEM)
A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Clinical trials underway show Stemcell research is not as slow as Gene Tech 30 years ago.
Recs
TAKE A LOOK AT THE INSIDER BUYING, SOMETHING GOOD IS HAPPENING.
Recs
This stock will increase after the November elections and will greatly improve the money needed for this important research project.
Recs
change of government thinking will push this higher
Recs
It doesn't matter if a democrat or republican wins the next election. It's when the current ignoramus isn't in office anymore, STEM will go up.
Recs
We shall not mix Church and State. Buy it before a Democrat gets elected or a Republican who draws the line between these two entities. This biotechnology will change much
Recs
Stem cells will make great strides.
Recs
Who doesn't want a backup heart or liver?
Recs
Stem cells are the future of medical solutions.
Recs
get in at $2 and cash out around $2.5
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 81 - 90 of 90 : « Previous 1 2 3 4 5